Poseida Therapeutics, Inc.
Total Trades
6
Buys
3
Sells
2
Largest Trade
$1M+
Insiders
4
Institutional Funds
1
Inst. Value
$100K–$500K
Activist Filings
14
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Gergen Mark J | Executive Chairman | EXERCISE | $50K–$100K | 30K | $2.78 | Nov 28, 2024 |
| Gergen Mark J | Executive Chairman | SELL | $100K–$500K | 30K | $9.27 | Nov 28, 2024 |
| Malin Life Sciences Holdings Ltd | 10% Owner | BUY | $1M+ | 2.1M | $3.50 | Aug 11, 2022 |
| Ostertag Eric | Executive Chairman | BUY | $100K–$500K | 143K | $3.50 | Aug 10, 2022 |
| Ostertag Eric | Executive Chairman | SELL | $500K+ | 161K | $3.69 | Aug 5, 2022 |
| Ingalls Kerry D. | COO | BUY | $1K–$15K | 3K | $3.98 | Mar 19, 2022 |
Institutional Ownership
13F filings as of Mar 31, 2025 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 100K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · May 15, 2025
0.0%
0 shares
SC 13G · Feb 14, 2025
5.2%
5.1M shares
SC 13G/A · Feb 7, 2025
0.0%
0 shares
SC 13G/A · Feb 7, 2025
10.3%
10.0M shares
Malin Life Sciences Holdings Limited
SC 13G/A · Jan 15, 2025
0.0%
0 shares
Pentwater Capital Management LP
SC 13D/A · Jan 13, 2025
0.0%
0 shares
Pentwater Capital Management LP
SC 13D/A · Nov 28, 2024
8.8%
8.6M shares
SC 13G · Nov 8, 2024
5.3%
5.1M shares
SC 13G · Oct 22, 2024
5.3%
5.1M shares
SC 13G/A · Jun 7, 2024
5.0%
4.8M shares
SC 13G/A · May 8, 2024
0.0%
0 shares
SC 13G · Jan 31, 2024
5.3%
5.0M shares
SC 13D · Aug 14, 2023
8.7%
8.3M shares
Pentwater Capital Management LP
SC 13D/A · Apr 25, 2022
7.9%
5.0M shares